Project Grant RF1DA060772

Award Date 9/30/24
Completion Date 9/29/27
Dollars Obligated $1.1M
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
New York, NY 10027, USA
Similar Awards
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,080,885 to the University of Southern California (USC) from September 2024 to September 2027. The funding supports the development of novel neural network models that can capture the nonlinear dynamics of large-scale brain networks and their relationship to behavior. The models will have flexible inference capabilities, enabling real-time,...
This federal Project Grant award of $811,112 was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant supports research by the University of California, San Francisco (UCSF) to investigate the brain networks and neural signaling mechanisms that underlie sudden "insight" learning of cue-reward associations. The key objectives are to use advanced techniques like two-photon calcium imaging, high-density...
This $284,040 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to conduct integrated single-cell and spatial mapping of the habenula circuitry to identify projection-specific molecular pathways associated with opioid exposure. The Lieber Institute for Brain Development in Baltimore, MD will lead this research effort from September 1, 2024 to August 31, 2026. The project will generate a...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $454,470.00 in funding to Drexel University to develop a new imaging pipeline and analytical approach for examining the spatial architecture of histone dopaminylation in the central nervous system (CNS) of mice with HIV infection that self-administer cocaine. The goal is to connect molecular-level epigenetic changes with behavioral outcomes...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $148,568 to investigate the mechanisms of dopamine transmission and its role in reward-related behaviors. The award period runs from January 1, 2025 to July 31, 2027. The funded research aims to advance the mechanistic understanding of how dopamine signaling occurs at the subcellular level, given limitations in prior methodologies. The...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $445,500.00 to the University of Alabama at Birmingham (UAB) to conduct high-throughput identification and characterization of conserved regulators of drug-induced plasticity in the Caenorhabditis elegans nervous system. The goal is to generate comprehensive molecular, behavioral, and neuronal activity atlases in response to acute and...
This $161,664 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support the development of a behavioral arena and computational framework to study social behaviors in Lake Malawi cichlids. The project aims to create tools to track animals and measure social behavioral dynamics within a natural environment mimicking context, including factors like hierarchy and male displays. This work will generate new...
This Project Grant award of $1,192,111, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund the development of the Ecosystem for Multi-Modal Brain-Behavior Experimentation and Research (EMBER) - a scalable, hybrid data archive tailored to serve the Brain Behavior Quantification and Synchronization (BBQS) research community. EMBER will house and manage multimodal, multi-species data collected by diverse research...
This federal Project Grant award of $180,606.00 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) is funding research to investigate cocaine-induced proteomic adaptations in the nucleus accumbens region of the brain. The principal investigator will use a combination of behavioral, cellular/molecular, and bioinformatic approaches to characterize the cell-type and circuit-specific synaptic proteome changes in response to cocaine...
The National Institute on Drug Abuse (NIDA) awarded a $300,290 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the Regents of the University of Minnesota. The 3-year grant, effective August 1, 2025, will fund a summer workshop program to train graduate students and junior researchers on conducting reproducible analysis of brain imaging and genomics data to study the relationship between genetic variants, brain structure/function, and mental health outcomes....

This federal Project Grant award, provided by the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop methods for integrating large-scale electron microscopy (EM) brain imaging data with functional and behavioral recordings. The $1,100,864 project, spanning from September 30, 2024 to September 29, 2027, will focus on relating the structure and function of neural circuits in the Drosophila brain. The proposed research seeks to create principled techniques for building and benchmarking connectome-constrained models that account for both connectivity data and functional/behavioral measurements. The methods developed will be scalable to datasets from larger organisms like mice, enabling their broader application across the field of neuroscience.

Generated 7/1/25, 4:04 AM